Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 12/20 | 0.55 |
| ▸ | ITGAV | P06756 | 5/20 | 0.55 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | TDO2 | P48775 | 1/20 | 0.41 |
| ▸ | ECE1 | P42892 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7596227 | 0.87 | ITGAV (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL7596670 | 0.85 | ITGAV (0.55) | ITGB3ITGAVFOLH1 | |
| SCHEMBL7591676 | 0.82 | ITGAV (0.39) | ITGB3ITGAV | |
| SCHEMBL7596092 | 0.80 | ITGB3 (0.54) | ITGB3ITGAVITGA2B | |
| SCHEMBL5711357 | 0.74 | FOLH1 (0.60) | ITGB3ITGAVSIRT2SIRT1FOLH1 | |
| SCHEMBL5711236 | 0.74 | FOLH1 (0.60) | ITGB3ITGAVSIRT2SIRT1FOLH1 | |
| SCHEMBL8387978 | 0.74 | FOLH1 (0.65) | ITGB3ITGAVSIRT2SIRT1ITGA2B | |
| SCHEMBL10421088 | 0.72 | FOLH1 (0.62) | ITGB3ITGAVSIRT2SIRT1ITGA2B | |
| SCHEMBL6421342 | 0.71 | ITGAV (1.00) | ITGB3ITGAV | |
| SCHEMBL6421344 | 0.71 | ITGAV (1.00) | ITGB3ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040098-A1 | INTEGRIN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (a New Jersey corp.) (US) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999031061-A1 | INTEGRIN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1999-06-24 | — | — | WO | disclosed |